ATELLICA TM IM TOTAL TRIIODOTHYRONINE - COFEPRIS Registration 1308R2018 SSA
Access comprehensive regulatory information for ATELLICA TM IM TOTAL TRIIODOTHYRONINE (ATELLICA TM IM TOTAL TRIIODOTHYRONINE) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1308R2018 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L DE C.V.. The device was registered on June 01, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ATELLICA™ IM TOTAL TRIIODOTHYRONINE (T3) ES PARA USO DIAGNÓSTICO IN VITRO EN LA DETERMINACIÓN CUANTITATIVA DE TRIYODOTIRONINA (T3) EN SUERO HUMANO. AGENTE DE DIAGNÓSTICO. PARA USO EXCLUSIVO EN LABORATORIOS CLÍNICOS O DE GABINETE. LÉASE INSTRUCTIVO DE
ATELLICA™ IM TOTAL TRIIODOTHYRONINE (T3) IS FOR IN VITRO DIAGNOSTIC USE IN THE QUANTITATIVE DETERMINATION OF TRIIODOTHYRONINE (T3) IN HUMAN SERUM. DIAGNOSTIC AGENT. FOR USE IN CLINICAL OR CABINET LABORATORIES ONLY. READ INSTRUCTIONS FROM